This article only represents the author's own views.
China may still be without a Covid-19 vaccine based on messenger RNA (mRNA) technology, generally considered the most effective for preventing infections. But many are racing to bring such vaccines to the country, even as the latest official data shows 1 billion Chinese have now been vaccinated using several homegrown shots based on older technologies.
That crowd gained another member last week when cancer and autoimmune disorder drug startup Everest Medicines Ltd. (1952.HK) announced a Chinese distribution deal for an mRNA jab being developed by Canada’s Providence Therapeutics Holdings Inc.
您已閱讀10%（650字），剩餘90%（5733字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。